^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
MERCURY™

Company:
Geneseeq
Type:
CE Marked
Related tests:

Details

Evidence
Mercury™ employs highly sensitive and high-throughput technology to target these biomarkers to detect cancer as early as possible using liquid biopsies. For early cancer detection, the in vitro diagnostic kit uses highly sensitive next-generation sequencing-based technology MERCURY™ to assess multi-omics features of circulating free DNA (cfDNA) and detect tumorigenesis in health population.
Cancer:
Solid Tumor
Method:
Next-Generation Sequencing (NGS) / Liquid biopsy
Approvals
Date
Cancer
Gene
Drug
By
01/24/23
CE